Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))

E. Dvir, J. E. Friedman, J. Y. Lee, J. Y. Koh, F. Younis, S. Raz, I. Shapiro, A. Hoffman, A. Dahan, G. Rosenberg, I. Angel, A. Kozak, Duvdevani

Research output: Contribution to journalComment/debate

Original languageAmerican English
Pages (from-to)1492
Number of pages1
JournalJournal of Pharmacology and Experimental Therapeutics
Volume319
Issue number3
StatePublished - 2006

Cite this